hemophilianewstoday5d
California center is first in state to offer Hympavzi for hemophilia B
The first hemophilia B patient at the Loma Linda University Health Hemophilia Treatment Center to receive Hympavzi is a ...
hemophilianewstoday5d
Flying through the air, even with hemophilia
Hemophilia may impose some limitations, but it doesn't stop columnist G Shellye Horowitz from finding ways to fly through the ...
hemophilianewstoday2d
What’s next after Pfizer’s gene therapy for hemophilia B is halted?
Columnist Jennifer Lynne assesses the effects of Pfizer's decision to halt production of its hemophilia B gene therapy, Beqvez.
hemophilianewstoday2d
Pfizer discontinues hemophilia B treatment Beqvez
Pfizer said it will discontinue gene therapy Beqvez (fidanacogene elaparvovec-dzkt), an approved hemophilia B treatment.
hemophilianewstoday3d
My family is enjoying a respite from complications of hemophilia
It's been several months since his sons have experienced complications of hemophilia, and columnist Joe MacDonald is grateful but anxious.
hemophilianewstoday4d
What it’s like managing hemophilia with an inhibitor, part 1
Every person with hemophilia is unique, especially with a complication like an inhibitor, columnist Cazandra Campos-MacDonald writes.
hemophilianewstoday6d
Household tools and appliances that make life with hemophilia easier
Columnist Alliah Czarielle discusses the benefits — and potential risks — of several tools that can be useful in a hemophilia household.
hemophilianewstoday3d
Marisa Wexler, MS, senior science writer—
The Loma Linda University Health (LLUH) Hemophilia Treatment Center has become the first clinic in California offering Hympavzi (marstacimab) for people with hemophilia B. “For the first time, ...